C-reactive protein is essential for innate resistance to pneumococcal infection

por Paul Simons, J, Loeffler, Jutta M, Al-Shawi, Raya, Ellmerich, Stephan, Hutchinson, Winston L, Tennent, Glenys A, Petrie, Aviva, Raynes, John G, de Souza, J Brian, Lawrence, Rachel A, Read, Kevin D, Pepys, Mark B
Publicado 2014

Isolation and characterization of pharmaceutical grade human pentraxins, serum amyloid P component and C‐reactive protein, for clinical use

por Pepys, Mark B., Gallimore, J. Ruth, Lloyd, Joanne, Li, Zhanhong, Graham, David, Taylor, Graham W., Ellmerich, Stephan, Mangione, Palma P., Tennent, Glenys A., Hutchinson, Winston L., Millar, David J., Bennett, Gary, More, John, Evans, David, Mistry, Yogesh, Poole, Stephen, Hawkins, Philip N.
Publicado 2012

Antibodies to human serum amyloid P component eliminate visceral amyloid deposits

por Bodin, Karl, Ellmerich, Stephan, Kahan, Melvyn C., Tennent, Glenys A., Loesch, Andrzej, Gilbertson, Janet A., Hutchinson, Winston L., Mangione, Palma P., Gallimore, J. Ruth, Millar, David J., Minogue, Shane, Dhillon, Amar P., Taylor, Graham W., Bradwell, Arthur R., Petrie, Aviva, Gillmore, Julian D., Bellotti, Vittorio, Botto, Marina, Hawkins, Philip N., Pepys, Mark B.
Publicado 2010